Literature DB >> 14954738

[Therapy of tuberculosis with neoteben (isonicotinic acid hydrazide)].

P KLEE.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; TUBERCULOSIS/therapy

Mesh:

Substances:

Year:  1952        PMID: 14954738     DOI: 10.1055/s-0028-1116025

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  8 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  [Bacteriological findings with neoteben].

Authors:  K LIEBERMEISTER
Journal:  Z Hyg Infektionskr       Date:  1953

3.  [The distribution of isonicotinic acid hydrazide in man].

Authors:  H JUNGBLUTH; F LEUSCHNER; K L RADENBACH
Journal:  Klin Wochenschr       Date:  1953-06-01

4.  [Quantitative microbiologic index of isonicotinic acid hydrazide in serum, spinal fluid and urine].

Authors:  F J GEKS
Journal:  Klin Wochenschr       Date:  1952-11-15

5.  ISONIAZID in pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1952-10-04

6.  [Experimental investigations on liver damage by Rimifon (isonicotinic acid hydrazide)].

Authors:  R EMMRICH; H PETZOLD
Journal:  Klin Wochenschr       Date:  1952-12-01

7.  [Effect of isonicotinic acid hydrazide (neoteben) on genital function and gestation; experimental examination with animals].

Authors:  M HESS
Journal:  Arch Gynakol       Date:  1954

8.  Antituberculosis drug-induced hepatotoxicity in children.

Authors:  Peter R Donald
Journal:  Pediatr Rep       Date:  2011-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.